Tao Synergies Inc. (TAOX) — SEC Filings

Tao Synergies Inc. (TAOX) — 31 SEC filings. Latest: 8-K (Dec 19, 2025). Includes 17 8-K, 6 10-Q, 3 DEF 14A.

View Tao Synergies Inc. on SEC EDGAR

Overview

Tao Synergies Inc. (TAOX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 19, 2025: TAO Synergies Inc. filed an 8-K on December 19, 2025, reporting on events from December 18, 2025. The filing covers the departure of directors, election of new directors, appointment of officers, and details on compensatory arrangements. It also includes information on matters submitted to a vote of

Sentiment Summary

Across 31 filings, the sentiment breakdown is: 4 bearish, 26 neutral, 1 mixed. The dominant filing sentiment for Tao Synergies Inc. is neutral.

Filing Type Overview

Tao Synergies Inc. (TAOX) has filed 17 8-K, 3 DEF 14A, 6 10-Q, 2 DEFA14A, 2 10-K, 1 SC 13G/A with the SEC between Feb 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent SEC Filings (31)

Tao Synergies Inc. SEC Filing History
DateFormDescriptionRisk
Dec 19, 20258-KTAO Synergies Inc. Files 8-K: Director Changes & Officer Appointmentsmedium
Nov 17, 2025DEF 14ATAOX Seeks Shareholder Nod for Major Dilutive Financing, Equity Plan Boosthigh
Nov 14, 202510-QTAOX Plunges into Crypto, Reports $21M Loss Amid Digital Asset Volatilityhigh
Oct 14, 20258-KTAO Synergies Inc. Files 8-K: Material Agreement & Equity Salesmedium
Aug 29, 20258-KTAO Synergies Inc. Files 8-K: Board Changes & Compensationmedium
Aug 14, 202510-QTAOX Pivots to Crypto, Reports $17.1M Loss Amidst Strategic Shifthigh
Aug 8, 20258-KTAO Synergies Inc. Appoints New CMO and Directorslow
Aug 6, 20258-KTAO Synergies Inc. Files 8-K, Relocates Officeslow
Jul 18, 2025DEFA14ATAO Synergies Files Proxy Statement Amendmentlow
Jul 17, 20258-KTAO Synergies Inc. Files 8-Klow
Jul 7, 2025DEF 14ATAOX Seeks Shareholder Nod for Dilutive Issuance, Equity Plan Boosthigh
Jun 27, 20258-KTAO Synergies Inc. Files 8-K with Executive Changesmedium
Jun 24, 20258-KSynaptogenix, Inc. Files 8-Klow
Jun 9, 20258-KSynaptogenix Announces Material Agreement, Officer Changesmedium
May 15, 202510-QSynaptogenix Q1 2025 10-Q Filedlow
Mar 27, 202510-KSynaptogenix Files 2024 10-K, Details Financial Inputsmedium
Dec 20, 20248-KSynaptogenix Files 8-K: Director/Officer Changes & Financialsmedium
Dec 6, 20248-KSynaptogenix Files 8-K on Security Holder Voteslow
Nov 20, 2024DEFA14ASynaptogenix Files Definitive Proxy Statementlow
Nov 12, 202410-QSynaptogenix Reports Q3 Loss, Revenue Growthmedium

Risk Profile

Risk Assessment: Of TAOX's 30 recent filings, 4 were flagged as high-risk, 14 as medium-risk, and 12 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Tao Synergies Inc. Financial Summary (10-Q, Nov 14, 2025)
MetricValue
Revenue$207,333
Net Income-$21,054,156
EPSN/A
Debt-to-Equity0.10
Cash Position$1,445,427
Operating Margin-307.3%
Total Assets$18,358,987
Total Debt$1,690,046

Key Executives

  • Joshua Silverman
  • Robert Weinstein
  • Special Committee
  • Dr. Jonathan S. Roth
  • Ms. Susan L. Roth
  • Mr. David L. Roth
  • Dr. David R. Spiegel

Industry Context

TAO Synergies Inc. operates in a dynamic sector where access to capital through equity financing is crucial for growth and development. Companies in this space often rely on preferred stock and warrant issuances to fund operations and strategic initiatives. The competitive landscape necessitates efficient capital management and strategic partnerships to navigate market fluctuations and regulatory requirements.

Top Tags

corporate-governance (9) · management-change (4) · financials (4) · filing (3) · material-agreement (3) · corporate-action (3) · filing-update (3) · proxy-statement (3) · amendment (3) · 10-Q (3)

Key Numbers

Tao Synergies Inc. Key Metrics
MetricValueContext
SEC File Number001-40458Identifies the company's filing with the SEC.
EIN461585656Employer Identification Number for TAO Synergies Inc.
Earliest Event Date20251218The date of the earliest event reported in the 8-K.
shares of Series E Preferred Stock11,000initially convertible into up to 1,375,000 shares of common stock
shares of Common Stock1,375,000underlying warrants issued in the private placement
threshold of common stock outstanding20%triggering Nasdaq Listing Rule 5635(d) for stockholder approval
shares500,000increase proposed for the 2020 Equity Incentive Plan
initial conversion price$8.00for Series E Preferred Stock and exercise price for GPN Warrants
shares of Common Stock outstanding6,718,912as of October 29, 2025, entitled to vote
shares of common stock underlying Series D Preferred Stock227,833as of October 29, 2025, entitled to vote
shares of common stock underlying Series E Preferred Stock738,987as of October 29, 2025, entitled to vote
stated value per share$1,000for Series D and Series E Preferred Stock
Net Loss$21.05MIncreased from $7.22M in 2024 for the nine months ended September 30, 2025
Cash and Cash Equivalents$1.45MDecreased from $17.66M at December 31, 2024
Crypto Currency Purchases$17.57MCash outflow for nine months ended September 30, 2025

Frequently Asked Questions

What are the latest SEC filings for Tao Synergies Inc. (TAOX)?

Tao Synergies Inc. has 31 recent SEC filings from Feb 2024 to Dec 2025, including 17 8-K, 6 10-Q, 3 DEF 14A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of TAOX filings?

Across 31 filings, the sentiment breakdown is: 4 bearish, 26 neutral, 1 mixed. The dominant sentiment is neutral.

Where can I find Tao Synergies Inc. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Tao Synergies Inc. (TAOX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Tao Synergies Inc.?

Key financial highlights from Tao Synergies Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for TAOX?

The investment thesis for TAOX includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Tao Synergies Inc.?

Key executives identified across Tao Synergies Inc.'s filings include Joshua Silverman, Robert Weinstein, Special Committee, Dr. Jonathan S. Roth, Ms. Susan L. Roth and 2 others.

What are the main risk factors for Tao Synergies Inc. stock?

Of TAOX's 30 assessed filings, 4 were flagged high-risk, 14 medium-risk, and 12 low-risk.

What are recent predictions and forward guidance from Tao Synergies Inc.?

Forward guidance and predictions for Tao Synergies Inc. are extracted from SEC filings as they are enriched.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.